The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0352-2020·Announced 2019-11-27

Altaire Recalls Perrigo Ophthalmic Ointment Due to Sterility Concerns

Altaire Pharmaceuticals is recalling Perrigo Neomycin and Polymixin B Sulfates and Dexamethasone Ophthalmic Ointment due to a lack of assurance of sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of serious injury or adverse health consequences.

Plain-English summary

Altaire Pharmaceuticals, Inc. is recalling Perrigo Neomycin and Polymixin B Sulfates and Dexamethasone Ophthalmic Ointment, Net. Wt 3.5 gm, Sterile, Rx only. The recall involves 1,737,549 containers distributed nationwide in the U.S.A. The product is manufactured for Perrigo Minneapolis, MN, and carries NDC 0574-4160-35.

The recall was initiated due to a lack of assurance of sterility. The affected lots include specific expiration dates ranging from July 2019 to March 2021, with lot numbers such as RGC, RHB, RHC, RID, RIC, RIG, RKH, RKI, RKJ, RKK, RKL, RLM, SAI, SBG, SBH, SCF, SEA, SFA, SFB, SHA, SIB, SJC, TAB, TAF, TBP, TBQ, TCV, and TCW.

Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or pharmacist for further instructions. The recall is classified as FDA Class II.

The recalled product

Product
Perrigo Neomycin and Polymixin B Sulfates and Dexamethasone Ophthalmic Ointment, Net. Wt 3.5 gm, Sterile, Rx only, Manufactured for Perrigo Minneapolis, MN 55427, NDC 0574-4160-35
Manufacturer
Altaire Pharmaceuticals, Inc.
Category
Drug — Ophthalmic
Hazard
Affected units
1,737,549

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot #: RGC
  • Exp 7/19
  • RHB
  • RHC
  • Exp 8/19
  • RID
  • RIC
  • RIG
  • Exp 9/19
  • RKH
  • RKI
  • RKJ
  • RKK
  • RKL
  • Exp 11/19
  • RLM
  • Exp 12/19
  • SAI
  • Exp 1/20
  • SBG

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 134 products in this recall →

Related recalls

Same manufacturer · Altaire Pharmaceuticals, Inc.

See all →

Same hazard · sterility

See all →

Similar recalls